WASHINGTON — President Trump boldly asserted Tuesday that his administration’s efforts to bring down drug prices had led to the largest drop in those figures in nearly half a century.

That’s not quite right.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Don’t put stuff on my Facebook feed that I have to pay to see or subscribe to. A waste of my time and isn’t going to happen. Makes me angry.

  • I have just been made aware of your publication thanks to NPR s site where I found an article imported from stat news. I was intrigued and wanted to know more but Immediately hit a roadblock i.e. Subscribe or forget it. Well unfortunately I cannot subscribe because I live on Social Security which Doesnot allow for Extras. I didnot and do not expect to get your publication for free. But to not allow me to get access to at least 2 or 3 articles a month seems penny wise and pound foolish, to paraphrase. I may not have much money but I do have quite a few friends whose interests, like mine, are wide ranging. And ‘word of mouth’ can be a powerful ‘thing’ 🙂. I could go on, but suffice to say, it honestly would be hard to recommend your site on the basis of one good article. So I ask that you reconsider your policy? and be alittle more generous with your writings availability. Thanks for reading this.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy